πŸ‡ΊπŸ‡Έ FDA
Patent

US 9410154

HBV treatment

granted A61PA61P31/20

Quick answer

US patent 9410154 (HBV treatment) held by Benitec Biopharma Limited expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Benitec Biopharma Limited
Grant date
Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P31/20